Chair persons and Office

The AG Pro Biosimilars is the interest platform of the biosimilar companies in Germany. It is represented by two chairpersons and the office. The two chairpersons and the staff of the Berlin office introduce themselves here.

Walter Röhrer

Chair

More Information

Walter Röhrer

The social scientist has been working in the pharmaceutical industry since 1999 and moved to Biogen GmbH (Munich) in 2015. There he has been part of the management team of the biosimilars business unit as Associate Director Market Access since April.

Dr. Christopher Kirsch

Vice-Chair

More Information

Dr. Christopher Kirsch

Dr. Christopher Kirsch is a pharmacist and has worked in the pharmaceutical industry since 2003. After many years of management in marketing/sales functions for Sandoz/Hexal, he has been responsible for Market Access for Sandoz Germany since 2018.

Bork Bretthauer

Managing Director

More Information

Bork Bretthauer

The political scientist worked as office manager for Federal Health Minister Andrea Fischer, later as a member of the executive board for the Association of Research-Based Pharmaceutical Companies. He has been managing director of Pro Generika since 2011.

Gloria von Schorlemer

Lawyer / Member of the Executive Board

More Information

Gloria von Schorlemer

Gloria von Schorlemer has been responsible for the legal department of Pro Generika since 2011. She has many years of experience in associations of the pharmaceutical industry. Before joining Pro Generika, she was, among other things, a lawyer in Berlin.

Anna Steinbach

Head of Communication / Member of the Executive Board

More Information

Anna Steinbach

After completing her traineeship at the Axel Springer School of Journalism, the German studies and history graduate worked for many years at daily newspapers and an advertising agency. Since 2019, she has been responsible for the area of communication.

Fabian Locher

Press speaker

More Information

Fabian Locher

The political scientist and sociologist initially worked in communications at the German Aerospace Centre (DLR). He has been campaigning for the interests of the pharmaceutical industry since 2018.

Frank Wittkemper, MBA

Head of Market Access

More Information

Frank Wittkemper, MBA

The biologist and health economist worked for Pfizer for 11 years in many indication areas, most recently as Head of Marketing in Oncology. He later worked for the KBV in the area of quality of care and was responsible for digitalisation, for example Digitisation.

Franziska Strobel M.A.

Assistant to the management

More Information

Franziska Strobel M.A.

Franziska Strobel, who has an M.A. in English/American Studies/Politics and Psychology, has been supporting the work of the AG since 2006. Previous positions include the exchange organisation CIEE and the media monitoring institute Landau Media.